ghk-cu muscle growth Peptide GHK-Cu Copper Peptide: The Ultimate
Description
Disclosure of interest: All of the authors: nothing to disclose
What is AOD-9604 and what is it used for in research
What the clinical evidence shows Phase 2 monotherapy trials: cagrilintide alone The Phase 2 clinical trial for cagrilintide monotherapy was published in The Lancet in 2021
p = 0.017]
